Adiuvo Investment SA (ADV) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.005x

Based on the latest financial reports, Adiuvo Investment SA (ADV) has a cash flow conversion efficiency ratio of -0.005x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł152.00K ≈ $41.83K USD) by net assets (zł-33.41 Million ≈ $-9.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ADV equity to assets ratio to measure how much of total assets are equity-financed.

Adiuvo Investment SA - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Adiuvo Investment SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Adiuvo Investment SA (ADV) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Adiuvo Investment SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Adiuvo Investment SA ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Bone Biologics Corp NASDAQ:BBLG	-0.133x
CQS Natural Resources Growth and Income plc LSE:CYN	-0.001x
Fimperkasa Utama Tbk PT JK:FIMP	-0.056x
Heads UP Ventures Limited NSE:HEADSUP	-0.078x
GeoVax Labs Inc NASDAQ:GOVX	-1.266x
Sabre Resources Ltd AU:SBR	-0.032x
3 E Network Technology Group Ltd Class A Ordinary Shares NASDAQ:MASK	-0.058x
Viver Incorporadora e Construtora S.A SA:VIVR3	-0.166x

Annual Cash Flow Conversion Efficiency for Adiuvo Investment SA (2013–2025)

The table below shows the annual cash flow conversion efficiency of Adiuvo Investment SA from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see Adiuvo Investment SA (ADV) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	zł-35.22 Million ≈ $-9.69 Million	zł-376.00K ≈ $-103.48K	0.011x	-89.15%
2024-12-31	zł-34.74 Million ≈ $-9.56 Million	zł-3.42 Million ≈ $-940.41K	0.098x	-11.66%
2023-12-31	zł-44.73 Million ≈ $-12.31 Million	zł-4.98 Million ≈ $-1.37 Million	0.111x	-30.70%
2022-12-31	zł-47.40 Million ≈ $-13.04 Million	zł-7.62 Million ≈ $-2.10 Million	0.161x	+120.31%
2021-12-31	zł7.30 Million ≈ $2.01 Million	zł-5.78 Million ≈ $-1.59 Million	-0.791x	-145.16%
2020-12-31	zł29.00 Million ≈ $7.98 Million	zł-9.36 Million ≈ $-2.58 Million	-0.323x	-250.10%
2019-12-31	zł46.72 Million ≈ $12.86 Million	zł-4.31 Million ≈ $-1.19 Million	-0.092x	+65.82%
2018-12-31	zł53.99 Million ≈ $14.86 Million	zł-14.56 Million ≈ $-4.01 Million	-0.270x	+56.99%
2017-12-31	zł51.55 Million ≈ $14.19 Million	zł-32.33 Million ≈ $-8.90 Million	-0.627x	-137.89%
2016-12-31	zł76.89 Million ≈ $21.16 Million	zł-20.27 Million ≈ $-5.58 Million	-0.264x	+10.86%
2015-12-31	zł60.86 Million ≈ $16.75 Million	zł-18.00 Million ≈ $-4.95 Million	-0.296x	-9.61%
2014-12-31	zł33.00 Million ≈ $9.08 Million	zł-8.90 Million ≈ $-2.45 Million	-0.270x	+67.54%
2013-12-31	zł4.34 Million ≈ $1.19 Million	zł-3.60 Million ≈ $-991.87K	-0.831x	--

About Adiuvo Investment SA

WAR:ADV Poland Medical Devices

Market Cap

$1.61 Million

zł5.86 Million PLN

Market Cap Rank

#30194 Global

#350 in Poland

Share Price

zł0.45

Change (1 day)

-2.41%

52-Week Range

zł0.39 - zł0.92

All Time High

zł31.50